Christopher Mark Lynne
Insider
First SEC filing: Oct. 14, 2025 · Latest: Oct. 14, 2025
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 25, 2026 | PXED | M | 75,260 | $11.04 | $830,870 | 251,638 Direct | +42.67% | Acquired | 125.4% (price as of 2026-10-05) |
| Aug. 25, 2026 | PXED | F | 45,249 | $28.74 | $1,300,456 | 206,389 Direct | -17.98% | Disposed | -13.4% (price as of 2026-10-05) |
| Aug. 25, 2026 | PXED | M | 75,260 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Oct. 9, 2025 | PXED | A | 277,200 | · | · | 277,200 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 9, 2025 | PXED | A | 277,200 | · | · | 277,200 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 9, 2025 | PXED | A | 115,584 | · | · | 115,584 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 9, 2025 | PXED | A | 75,260 | · | · | 75,260 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 9, 2025 | PXED | A | 152,340 | · | · | 176,378 Direct | +633.75% | Acquired | (price as of 2026-10-05) |
| Oct. 9, 2025 | PXED | A | 24,038 | · | · | 24,038 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 25, 2026 | PXED | Employee Stock Option (Right to Buy) | Common Stock | $11.04 | Aug. 31, 2026 | 75,260 | Disposed |
| Oct. 9, 2025 | PXED | Employee Stock Option (Right to Buy) | Common Stock | $10.61 | Aug. 31, 2030 | 277,200 | Acquired |
| Oct. 9, 2025 | PXED | Employee Stock Option (Right to Buy) | Common Stock | $10.61 | Feb. 17, 2033 | 277,200 | Acquired |
| Oct. 9, 2025 | PXED | Employee Stock Option (Right to Buy) | Common Stock | $5.23 | Nov. 12, 2028 | 115,584 | Acquired |
| Oct. 9, 2025 | PXED | Employee Stock Option (Right to Buy) | Common Stock | $11.04 | Aug. 31, 2026 | 75,260 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).